Literature DB >> 7050408

Spontaneous regression of genitourinary cancer--an update.

S E Katz, H E Schapira.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7050408     DOI： 10.1016/s0022-5347(17)52725-1

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  5 in total

Review 1.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

2.  Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes.

Authors:  S Ikemoto; S Wada; M Kamizuru; N Hayahara; T Kishimoto; M Maekawa
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

3.  Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence.

Authors:  W de Riese; K Goldenberg; E Allhoff; C Stief; R Schlick; S Liedke; U Jonas
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

4.  Expression of blood group antigens in urinary tract tumours: prospective fluorescence study using cryostat sections of fresh frozen tissues.

Authors:  S J Thorpe; P Abel; D Henderson; N Jones; T Feizi
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

5.  Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.

Authors:  R Henriksson; S Nilsson; S Colleen; P Wersäll; M Helsing; R Zimmerman; K Engman
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.